VivoSeq
Other

Fallopian Tube

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Fallopian Tube is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Completed5 · 71%
Active, not recruiting1 · 14%
Not yet recruiting1 · 14%

Clinical Trials

Trial Activity

7 trials

Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube
Active, not recruiting·UUniversity of Oklahoma·Phase 1·NCT03771651·18 enrolled
Effect of Shockwaves on Fallopian Tubes Adhesion
Not yet recruiting·—·N/A·NCT06755528·40 enrolled
Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma
Completed·HH. Lee Moffitt Cancer Center and Research Institute·Phase 2·NCT00504257·45 enrolled
Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Completed·—·Phase 2·NCT00138242·30 enrolled
Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Completed·National Cancer Institute (NCI)·Phase 2·NCT01305213·107 enrolled
Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum
Completed·MMemorial Sloan Kettering Cancer Center·Phase 2·NCT00012090
Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Completed·National Cancer Institute (NCI)·Phase 2·NCT01468909·106 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)